Medinotec Inc.
MDNC
$5.00
$0.000.00%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 82.18% | 158.20% | 409.64% | 380.28% | 402.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 82.18% | 158.20% | 409.64% | 380.28% | 402.23% |
| Cost of Revenue | 66.23% | 212.66% | 814.58% | 627.80% | 517.17% |
| Gross Profit | 99.02% | 110.99% | 229.36% | 245.37% | 319.80% |
| SG&A Expenses | -14.32% | 41.54% | 129.03% | 107.66% | 150.10% |
| Depreciation & Amortization | 15.49% | 126.68% | 113.69% | 61.77% | 19.44% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.72% | 133.52% | 349.98% | 267.19% | 256.96% |
| Operating Income | 431.39% | 375.40% | 1,438.04% | 653.71% | 351.72% |
| Income Before Tax | 1,292.00% | 351.39% | 477.93% | 79.15% | 35.20% |
| Income Tax Expenses | 473.41% | 828.21% | 3,458.93% | 1,512.63% | 490.67% |
| Earnings from Continuing Operations | 633.58% | 237.71% | 80.25% | -27.12% | -14.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 633.58% | 237.71% | 80.25% | -27.12% | -14.74% |
| EBIT | 431.39% | 375.40% | 1,438.04% | 653.71% | 351.72% |
| EBITDA | 374.13% | 318.31% | 778.12% | 1,303.13% | 527.50% |
| EPS Basic | 674.50% | 249.03% | 89.36% | -10.19% | 9.85% |
| Normalized Basic EPS | 561.64% | 1,198.28% | 1,149.06% | 346.53% | 197.48% |
| EPS Diluted | 674.50% | 249.03% | 89.36% | -10.19% | 9.85% |
| Normalized Diluted EPS | 561.64% | 1,198.28% | 1,149.06% | 346.53% | 197.48% |
| Average Basic Shares Outstanding | 6.66% | -6.69% | -1.36% | -8.45% | 6.02% |
| Average Diluted Shares Outstanding | 6.66% | -6.69% | -1.36% | -8.45% | 6.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |